1. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature
- Author
-
Lisbeth A. Guethlein, Tracy L. Bergemann, Valarie McCullar, Jeffrey S. Miller, Michelle K. Gleason, Peter Parham, Sarah Cooley, Michelle Pitt, Karina L. McQueen, and Feng Xiao
- Subjects
Genotype ,Immunology ,Cell Culture Techniques ,chemical and pharmacologic phenomena ,Biology ,Biochemistry ,Natural killer cell ,Major Histocompatibility Complex ,Interferon-gamma ,Interleukin 21 ,NK-92 ,medicine ,Humans ,Receptors, Immunologic ,Immunobiology ,DNA Primers ,Ego ,Lymphokine-activated killer cell ,Reverse Transcriptase Polymerase Chain Reaction ,Janus kinase 3 ,Cell Biology ,Hematology ,Flow Cytometry ,NKG2D ,CD56 Antigen ,Killer Cells, Natural ,Self Tolerance ,medicine.anatomical_structure ,NK Cell Lectin-Like Receptor Subfamily K ,Interleukin 12 ,Receptors, Natural Killer Cell ,NK Cell Lectin-Like Receptor Subfamily C - Abstract
How receptor acquisition correlates with the functional maturation of natural killer (NK) cells is poorly understood. We used quantitative real-time polymerase chain reaction (PCR) assays to compare NKG2 and killer immunoglobulin-like receptor (KIR) gene expression in NK cells from allogeneic transplant recipients and their donors. Marked differences were observed in the NK subsets of recipients who had 8-fold more CD56bright cells, diminished KIR expression (except 2DL4), and increased NKG2A. In normal blood not all CD56dim cells express KIR, and a novel subpopulation of cells committed to the NK-cell lineage was defined. These cells, which comprise 19.4% ± 2.8% of the CD56dim NK population in healthy donors, express the activating NKG2D and NKG2E receptors but no KIR or NKG2A. Although the CD56dim NKG2A− KIR− NK cells lack “at least one” inhibitory receptor for autologous MHC class I, they are not fully responsive, but rather functionally immature cells with poor cytotoxicity and IFN-γ production. Upon culture with IL-15 and a stromal cell line, CD56dim and CD56bright KIR− NK cells proliferate, express KIR, and develop cytotoxicity and cytokine-producing potential. These findings have implications for the function of NK cells reconstituting after transplantation and support a model for in vivo development in which CD56bright cells precede CD56dim cells.
- Published
- 2007
- Full Text
- View/download PDF